BrainZell AB
559261-5347ActiveScaling human brain organoids accelerate novel CNS drug discovery testing.
Biotechnology Companybrainzell.com
Yleiskatsaus
- 5–9
- Työntekijät
- 200–299t SEK
- Liikevaihto
- 2020
- Perustettu
Avainpäättäjät
Robin Pronk
CSO & Co-founder
Petra Szeszula
CEO & Co-founder
Jacopo Biasetti
Head of Computational Biology
Matija Rojnik
Head of Business Development
+2 lisää yhteystietoja Funnelfeedrissä
Kuvaus
BrainZell is a biotechnology company pioneering the future of central nervous system (CNS) drug development. They specialize in generating scalable, high-throughput brain organoids derived from induced pluripotent stem cells (iPSCs). Their innovative platform faithfully mimics human neural biology,...